Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873989 · ClinicalTrials.gov registry record · Phase 1
Testosterone Replacement for Male Opioid Agonist Maintained Patients
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01873989: Completed Phase 1 study, sponsored by Yale University.
NCT01873989 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873989, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
Primary Outcome
Number of participants who provided four consecutive weekly urines that were negative for illicit opioids in weeks 5 through 8.
Interventions
- OTHER Waitlist control
- DRUG Testosterone replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
What the finished NCT01873989 record still lists
NCT01873989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Waitlist control is the first listed.
NCT01873989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01873989 about?
NCT01873989 is a clinical study titled "Testosterone Replacement for Male Opioid Agonist Maintained Patients". This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
What is the current status of trial NCT01873989?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01873989?
The interventions under investigation include: Waitlist control (OTHER), Testosterone replacement (DRUG).
Who is sponsoring clinical trial NCT01873989?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01873989's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia